Invivyd Inc. share price logo

Invivyd Inc.

NASDAQ: IVVD

Small Cap

$0.90

-0.03

(-3.66%)

Live

as on

Invivyd Inc. Stock Performance

as on August 27, 2026 at 5:14 am IST

  • Day's Low

    Day's High

    $0.84
    $0.92
    downward going graph

    6.67%

    Downside

    2.22%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.53
    $3.07
    downward going graph

    41.37%

    Downside

    241.10%

    Upside

    downward going graph

Invivyd Inc. share price movements today

Previous Close
$0.94
Open
$0.92
Volume
3.1M
Market Cap
$277.8M
Day's Low - High
$0.84 - $0.92
52 Week Low - High
$0.53 - $3.07

Invivyd Inc. Historical Returns

1 Month Return
+ 53.53 %
3 Month Return
-14.66 %
1 Year Return
-8.86 %
3 Year Return
-49.53 %
5 Year Return
0 %

Invivyd Inc. Stock Fundamentals & Key Indicators

Check Invivyd Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$277.8M

EPS (TTM)

-0.57

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-111.9M

Revenue (TTM)

58.4M

Profit Margin

-183.90%

Return On Equity TTM

-95.89%

Invivyd Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Invivyd Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Invivyd Inc. image
Invivyd Inc.
BUY$277.8MNANA-183.90%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$45.3B670.9%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$138.8B178.87%31.9535.00%NA
Moderna Inc. image
Moderna Inc.
BUY$55.4B-60.32%NA-141.43%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$85.3B25.2%20.6227.87%0.44%

Stock Returns calculator for Invivyd Inc. Stock including INR - Dollar returns

The Invivyd Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Invivyd Inc. investment value today

Current value as on today

₹95,123

Returns

-₹4,877

(-4.88%)

Returns from Invivyd Inc. Stock

-₹12,621 (-12.62%)

Dollar Impact

₹7,745 (+7.74%)

Analyst Recommendation on Invivyd Inc. Stock

Based on 10 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 10 analysts, 80% of analysts recommend a 'BUY' rating for Invivyd Inc.. Average target price of $10

Invivyd Inc. Share Price Target

Get share price movements and forecasts by analysts on Invivyd Inc..

What analysts predicted

91%UPSIDE

Target Price

$10

Current Price

$0.9

Analyzed by

10 Analysts

Target

$10.00

Invivyd Inc. target price $10, a slight upside of 91% compared to current price of $0.9. According to 10 analysts rating.

Indian Investors' Interest in Invivyd Inc. Stock

Search interest for Invivyd Inc. Stock has decreased by -62% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-62% versus previous 30 day period

Invivyd Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
2
9
13
11
11
13
17
13
14
Gross Profit
0
2
8
13
10
11
12
16
12
13
Operating Income
-46
-49
-62
-19
-16
-15
-11
-12
-43
-45
EBITDA
-42
-46
-60
-16
-15
-14
-10
-10
-40
-45
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
1
0
0
0
0
0
-
Income Before Tax
-43
-47
-60
-18
-16
-14
-10
-11
-41
-44
Income Tax Expense
0
-
-
0
-
-
-
-
-
-
Net Income
-43
-47
-60
-18
-16
-14
-10
-11
-41
-44
Net Profit Margin
0.00%
-2086.88%
-653.11%
-133.45%
-144.10%
-124.38%
-79.75%
-64.33%
-301.22%
-310.77%

Invivyd Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
25
53
Gross Profit
0
0
-2
23
49
Operating Income
-226
-248
-212
-176
-55
EBITDA
-219
-225
-205
-166
-50
Interest Expense
14
43
-
-
-
Depreciation
0
0
1
3
2
Income Before Tax
-226
-241
-198
-169
-52
Income Tax Expense
7
-6
-
-
-
Net Income
-226
-241
-198
-169
-52
Net Profit Margin
0.00%
0.00%
0.00%
-669.42%
-98.25%

Invivyd Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-47
-60
-18
-16
-14
-10
-11
-41
-44
Operating Cash Flow
-41
-41
-37
-21
-13
-8
-15
-41
-43
Investing Cash Flow
-
0
0
0
0
-
-
0
0
Financing Cash Flow
0
0
0
0
0
58
157
0
19
Change in Cash
-41
-41
-37
-21
-13
50
141
-42
-24

Invivyd Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-226
-241
-198
-169
-52
Operating Cash Flow
-184
-219
-173
-170
-58
Investing Cash Flow
-50
-230
280
0
0
Financing Cash Flow
662
0
1
39
215
Change in Cash
427
-450
108
-131
157

Global Institutional Holdings in Invivyd Inc.

Funds
Holdings
State Street Corp
2.35%
Geode Capital Management, LLC
0.73%
ADAR1 Capital Management LLC
1.3%
Millennium Management LLC
0%
StemPoint Capital LP
1.27%
See all

Invivyd Inc. News & Key Events

    Insights on Invivyd Inc.

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 1 month, IVVD stock has moved up by 53.5%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Revolution Medicines, Inc. Common Stock has given 41.9% return, outperforming this stock by 91.4%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 542.3% return, outperforming this stock by 551.2%

    About Invivyd Inc.

    Invivyd, Inc., together with its subsidiaries, engages in the research, development, commercialization, and sale of antibody therapies for the prevention and treatment of viral infectious diseases in the United States. The company offers Pemivibart, a half-life extended investigational monoclonal antibody for the pre-exposure prophylaxis prevention of COVID-19 in adults and adolescents through injection under the PEMGARDA brand. It also develops VYD2311, a monoclonal antibody, which is in Phase III clinical trial for the prevention and treatment of SARS-CoV-2 virus; and VBY329, a monoclonal antibody, which is in pre-clinical trial stage for the prevention and treatment of respiratory syncytial virus and measles in neonates, infants, and children. It has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in New Haven, Connecticut.
    OrganisationInvivyd Inc.
    Headquarters209 Church Street, New Haven, CT, United States, 06510
    IndustryBiotechnology
    CEOMr. William E. Duke Jr., M.B.A.
    E-voting on sharesClick here to vote

    Key Management of Invivyd Inc.

    Name

    Title

    Ms. Julie Green M.B.A.

    Chief Human Resources Officer

    Ms. Rachael Gerlach Ph.D.

    Senior Vice President of Regulatory Affairs

    Ms. Katie Falzone CPA

    Senior Vice President of Finance

    Mr. William E. Duke Jr., M.B.A.

    CFO, Principal Accounting Officer & Principal Executive Officer

    Ms. Jill Andersen J.D.

    Chief Legal Officer & Corporate Secretary

    Mr. Timothy Lee

    Chief Commercial Officer

    Dr. Robert D. Allen Ph.D.

    Chief Scientific Officer

    Ms. Kristie Coneys Kuhl J.D.

    Chief Communications Officer

    FAQs

    What is Invivyd Inc. share price today?

    Invivyd Inc. share price today is $0.90 as on . Invivyd Inc. share today touched a day high of $0.92 and a low of $0.84.

    What is the 52 week high and 52 week low for Invivyd Inc. share?

    Invivyd Inc. share touched a 52 week high of $3.07 on and a 52 week low of $0.53 on . Invivyd Inc. stock price today i.e. is trending at $0.90,which is 70.68% down from its 52 week high and 70.55% up from its 52 week low.

    What is Invivyd Inc.'s market capitalisation today?

    Invivyd Inc. market capitalisation is $0.00T as on .

    How to invest in Invivyd Inc. Stock (IVVD) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Invivyd Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Invivyd Inc. Shares that will get you 1.6667 shares as per Invivyd Inc. share price of $0.90 per share as on August 26, 2026 at 11:44 pm IST.

    What is the minimum amount required to buy Invivyd Inc. Stock (IVVD) from India?

    Indian investors can start investing in Invivyd Inc. (IVVD) shares with as little as ₹95.402 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹954.02 in Invivyd Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Invivyd Inc. share’s latest price of $0.90 as on August 26, 2026 at 11:44 pm IST, you will get 11.1111 shares of Invivyd Inc.. Learn more about fractional shares .